Abeona Therapeutics Inc (NASDAQ: ABEO) is -15.98% lower on its value in year-to-date trading and has touched a low of $3.05 and a high of $8.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABEO stock was last observed hovering at around $4.45 in the last trading session, with the day’s gains setting it 0.23%.
Currently trading at $4.68, the stock is -8.31% and -12.80% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.24 million and changing 5.17% at the moment leaves the stock -15.46% off its SMA200. ABEO registered -39.38% loss for a year compared to 6-month loss of -25.95%. The firm has a 50-day simple moving average (SMA 50) of $5.3668 and a 200-day simple moving average (SMA200) of $5.53605.
The stock witnessed a -7.69% gain in the last 1 month and extending the period to 3 months gives it a -16.58%, and is -6.21% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.48% over the week and 5.77% over the month.
Abeona Therapeutics Inc (ABEO) has around 136 employees, a market worth around $227.14M and $0.00M in sales. Distance from 52-week low is 53.44% and -44.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-105.64%).
The EPS is expected to grow by 20.86% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
82.0 institutions hold shares in Abeona Therapeutics Inc (ABEO), with institutional investors hold 72.03% of the company’s shares. The shares outstanding are 45.64M, and float is at 42.86M with Short Float at 5.57%. Institutions hold 68.52% of the Float.
Abeona Therapeutics Inc (ABEO) Insider Activity
The most recent transaction is an insider sale by Seshadri Vishwas, the company’s Chief Executive Officer. SEC filings show that Seshadri Vishwas sold 25,000 shares of the company’s common stock on Mar 31 ’25 at a price of $4.78 per share for a total of $0.12 million. Following the sale, the insider now owns 1.36 million shares.
Still, SEC filings show that on Jan 29 ’25, Alvino Mark (Director) disposed off 4,000 shares at an average price of $5.38 for $21520.0. The insider now directly holds 64,334 shares of Abeona Therapeutics Inc (ABEO).
